686 filings
8-K
ELTP
Elite Pharmaceuticals Inc
14 Feb 24
Elite Pharmaceuticals, Inc. Reports Financial Results for Third Quarter of Fiscal Year 2024
4:55pm
10-Q
2024 Q3
ELTP
Elite Pharmaceuticals Inc
Quarterly report
14 Feb 24
4:06pm
4
ELTP
Elite Pharmaceuticals Inc
29 Dec 23
ELITE PHARMACEUTICALS / Nasrat A Hakim ownership change
2:21pm
8-K
ELTP
Elite Pharmaceuticals Inc
26 Dec 23
Regulation FD Disclosure
4:20pm
8-K
ELTP
Elite Pharmaceuticals Inc
12 Dec 23
Elite Pharmaceuticals Announces First Product Shipment of Generic Adderall XR® to Marketing Partner Prasco, LLC
4:20pm
4
Jeffrey A Whitnell
27 Nov 23
ELITE PHARMACEUTICALS / JEFFREY A WHITNELL ownership change
7:05pm
4
ELTP
Elite Pharmaceuticals Inc
27 Nov 23
ELITE PHARMACEUTICALS / Davis S Caskey ownership change
6:58pm
4
Barry H Dash
27 Nov 23
ELITE PHARMACEUTICALS / Barry H Dash ownership change
6:50pm
8-K
ELTP
Elite Pharmaceuticals Inc
14 Nov 23
Results of Operations and Financial Condition
5:22pm
10-Q
2024 Q2
ELTP
Elite Pharmaceuticals Inc
Quarterly report
14 Nov 23
4:16pm
8-K
ELTP
Elite Pharmaceuticals Inc
25 Sep 23
Regulation FD Disclosure
4:15pm
8-K
ELTP
Elite Pharmaceuticals Inc
7 Sep 23
Elite Pharmaceuticals, Inc. Appoints Carter Ward as Chief Financial Officer
4:05pm
8-K
ELTP
Elite Pharmaceuticals Inc
14 Aug 23
Elite Pharmaceuticals, Inc. Reports Financial Results for First Quarter of Fiscal Year 2024
5:30pm
10-Q
2024 Q1
ELTP
Elite Pharmaceuticals Inc
Quarterly report
14 Aug 23
4:06pm
8-K
ELTP
Elite Pharmaceuticals Inc
17 Jul 23
Changes in Registrant's Certifying Accountant
4:15pm
8-K
ELTP
Elite Pharmaceuticals Inc
29 Jun 23
Results of Operations and Financial Condition
5:15pm
10-K
2023 FY
ELTP
Elite Pharmaceuticals Inc
Annual report
29 Jun 23
4:43pm
4
Plassche Douglas
26 Jun 23
ELITE PHARMACEUTICALS / Douglas Plassche ownership change
12:46pm
3
ELTP
Elite Pharmaceuticals Inc
8 May 23
ELITE PHARMACEUTICALS / Mark N Pellegrino ownership change
3:13pm